
Surmodics SRDX
Quartalsbericht 2025-Q2
hinzugefügt 08.08.2025
Surmodics P/CF 2011-2026 | SRDX
P/CF Jährlich Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.23 K | 45.7 | -29.4 | 40.1 | 50.3 | 487 | 42 | 50.7 | 19.2 | 21.1 | 18.5 | 22.3 | 21.5 | 11.5 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.23 K | -29.4 | 217 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
8.14 | $ 8.99 | 1.35 % | $ 599 M | ||
|
Brainsway Ltd.
BWAY
|
271 | $ 13.76 | 0.77 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 26.01 | 0.68 % | $ 722 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
17.7 | $ 68.19 | 2.8 % | $ 26.6 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Guardant Health
GH
|
-72.7 | $ 88.32 | 1.3 % | $ 11.1 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 153.95 | 1.3 % | $ 7.63 B | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 17.5 | 1.01 % | $ 933 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | $ 103.93 | 0.07 % | $ 19.6 B | ||
|
IQVIA Holdings
IQV
|
10.7 | $ 168.51 | 2.2 % | $ 29 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 15.53 | 3.88 % | $ 470 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
-1.89 | $ 16.83 | -2.66 % | $ 2.18 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 99.62 | 2.06 % | $ 8.22 B | ||
|
Anixa Biosciences
ANIX
|
-0.0144 | $ 2.87 | 1.06 % | $ 93.1 K | ||
|
Danaher Corporation
DHR
|
23.3 | $ 195.42 | 2.11 % | $ 139 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
-4.48 | $ 1.42 | 4.04 % | $ 426 M | ||
|
Illumina
ILMN
|
19.6 | $ 122.4 | 2.62 % | $ 19.5 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 199.02 | 0.04 % | $ 22.1 B | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
28.3 | $ 113.92 | 1.87 % | $ 34.6 B | ||
|
BioNano Genomics
BNGO
|
-0.0515 | $ 1.13 | 1.8 % | $ 1.44 M | ||
|
DarioHealth Corp.
DRIO
|
-1.43 | $ 9.28 | 10.24 % | $ 263 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.33 | 1.09 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.24 | 1.48 % | $ 2 B | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 79.18 | 0.87 % | $ 5.34 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 455.81 | 0.48 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
29.7 | $ 1 220.02 | 1.78 % | $ 25.1 B | ||
|
Celcuity
CELC
|
-4.78 | $ 113.6 | -1.13 % | $ 4.48 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 17.83 | 2.47 % | $ 399 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 46.89 | 4.18 % | $ 2.8 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-12.3 | $ 200.13 | 1.24 % | $ 19.7 B |